Merit Medical Systems (NASDAQ:MMSI) Updates FY 2025 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 3.580-3.700 for the period, compared to the consensus EPS estimate of 3.740. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on MMSI shares. Raymond James lifted their price objective on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. Canaccord Genuity Group reduced their price target on Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating on the stock in a report on Wednesday. Piper Sandler reissued an “overweight” rating and set a $116.00 price target (up previously from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Robert W. Baird raised their price objective on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a research report on Thursday, October 31st. Finally, Needham & Company LLC reduced their target price on shares of Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a research note on Wednesday. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $108.40.

Merit Medical Systems Trading Down 1.9 %

Shares of MMSI traded down $1.93 during trading on Thursday, reaching $98.52. 589,097 shares of the company traded hands, compared to its average volume of 531,268. The stock has a 50-day simple moving average of $102.79 and a 200-day simple moving average of $99.89. The stock has a market cap of $5.74 billion, a PE ratio of 48.29, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. Merit Medical Systems has a twelve month low of $70.70 and a twelve month high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.